Bionaut Labs
Paul Schultz is a seasoned business development and strategy executive with extensive experience in the biopharmaceutical and digital health sectors. Currently serving as SVP Business Development & Strategy at Bionaut Labs, Paul leads initiatives in micro-robotic CNS drug delivery. Previously, Paul held various leadership roles at BrightInsight, including VP Global Accounts, where notable achievements included managing commercial partnerships with major biopharma companies such as Sanofi and CSL Behring. As Co-Founder and CEO of Nurep, a telehealth platform acquired by Mendaera, Paul drove significant funding and deployment successes. With a strong background in partnership development and commercialization, complemented by academic credentials in biotechnology and business, Paul has contributed to the growth of several startups and major corporations in healthcare.
This person is not in any teams
This person is not in any offices
Bionaut Labs
1 followers
Bionauts are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely.